These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34139028)

  • 1. Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
    Müller-Olling M; Vahlensieck U; Hilger A
    Clin Pharmacol Ther; 2022 May; 111(5):995-1000. PubMed ID: 34139028
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
    Focosi D; Tuccori M; Antonelli G; Maggi F
    Clin Microbiol Infect; 2021 Feb; 27(2):163-165. PubMed ID: 33007479
    [No Abstract]   [Full Text] [Related]  

  • 3. Position paper on the use of COVID-19 convalescent plasma: an update.
    Prati D; Fiorin F; Berti P; De Silvestro G; Accorsi P; Ostuni A;
    Blood Transfus; 2021 Jul; 19(4):277-280. PubMed ID: 34059190
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO covid-19 drugs guideline: reconsider using convalescent plasma.
    Paneth N; Casadevall A; Pirofski LA; Henderson JP; Grossman BJ; Shoham S; Joyner MJ
    BMJ; 2022 Feb; 376():o295. PubMed ID: 35135758
    [No Abstract]   [Full Text] [Related]  

  • 5. Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    Estcourt L; Callum J
    N Engl J Med; 2022 May; 386(18):1753-1754. PubMed ID: 35507487
    [No Abstract]   [Full Text] [Related]  

  • 6. A Public Option for Clinical Trials? Lessons from Convalescent Plasma.
    Roy V; Ross JS; Ramachandran R
    J Law Med Ethics; 2024; 52(1):98-100. PubMed ID: 38818610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma - this is no time for competition.
    Farrugia A; MacPherson J; Busch MP
    Transfusion; 2020 Jul; 60(7):1644-1646. PubMed ID: 32533558
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19.
    Dhanasekaran S; Vajravelu LK; Venkatesalu V
    Postgrad Med J; 2021 Jul; 97(1149):467-468. PubMed ID: 32817576
    [No Abstract]   [Full Text] [Related]  

  • 9. The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma.
    Baker JV; Lane HC
    Ann Intern Med; 2022 Sep; 175(9):1332-1334. PubMed ID: 35969864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 11. Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
    Sahu KK; Jindal V; Siddiqui AD; Cerny J; Gerber JM
    J Med Virol; 2020 Nov; 92(11):2251-2253. PubMed ID: 32437024
    [No Abstract]   [Full Text] [Related]  

  • 12. Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).
    Alghamdi AN; Abdel-Moneim AS
    Front Public Health; 2020; 8():437. PubMed ID: 32903641
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report.
    Yulianti M; Johan C; Singh G; Tenda ED; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2021 Oct; 53(4):497-504. PubMed ID: 35027500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent plasma to treat COVID-19: Following the Argentinian lead.
    Tiberghien P; Toussirot E; Richard P; Morel P; Garraud O
    Transfus Apher Sci; 2021 Jun; 60(3):103161. PubMed ID: 34045121
    [No Abstract]   [Full Text] [Related]  

  • 16. The Association Between Convalescent Plasma Treatment and Survival of Patients with COVID-19.
    Kuno T; Takahashi M; Egorova NN
    J Gen Intern Med; 2021 Aug; 36(8):2528-2531. PubMed ID: 33987794
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire!
    Marwah V; Choudhary R; Peter D; Bhati G
    Adv Respir Med; 2021; 89(3):347-349. PubMed ID: 33881163
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma.
    Wright Z; Bersabe A; Eden R; Bradley J; Cap A
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):66-68. PubMed ID: 32682684
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
    Hartog N; Holsworth A; Rajasekaran S
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):122-123. PubMed ID: 33161152
    [No Abstract]   [Full Text] [Related]  

  • 20. Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.
    Zhang LL; Liu Y; Guo YG; Chang J; Gao B; Li ZZ; Geng W; Hu P; Song B; Zhang X; Wan CC
    Turk J Haematol; 2021 Feb; 18(1):74-76. PubMed ID: 32988811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.